These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30903681)

  • 1. Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.
    Huang ZM; Li PL; Yang P; Hou XD; Yang YL; Xu X; Xu F
    Kaohsiung J Med Sci; 2019 Jun; 35(6):332-340. PubMed ID: 30903681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.
    Li H; Li J; Su Y; Fan Y; Guo X; Li L; Su X; Rong R; Ying J; Mo X; Liu K; Zhang Z; Yang F; Jiang G; Wang J; Zhang Y; Ma D; Tao Q; Han W
    Oncogene; 2014 Jun; 33(24):3109-18. PubMed ID: 23893243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX10-dependent CMTM7 expression inhibits cell proliferation and tumor growth in gastric carcinoma.
    Jin Y; Qin X; Jia G
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):91-99. PubMed ID: 30392914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis.
    Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C
    Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
    Tao JL; Luo M; Sun H; Zhao HM; Sun QS; Huang ZM
    Kaohsiung J Med Sci; 2020 Jun; 36(6):417-422. PubMed ID: 32052576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.
    Liu B; Su Y; Li T; Yuan W; Mo X; Li H; He Q; Ma D; Han W
    Oncotarget; 2015 Dec; 6(38):41092-107. PubMed ID: 26528697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells.
    Li W; Zhang S
    Oncol Res; 2017 Jan; 25(2):285-293. PubMed ID: 27629543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma.
    Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
    Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
    Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.
    Ye D; Luo H; Lai Z; Zou L; Zhu L; Mao J; Jacob T; Ye W; Wang L; Chen L
    Sci Rep; 2016 Jul; 6():30276. PubMed ID: 27451945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.
    Wang Y; Zhou X; Shan B; Han J; Wang F; Fan X; Lv Y; Chang L; Liu W
    Mol Med Rep; 2015 Nov; 12(5):6491-500. PubMed ID: 26352175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27.
    Kim JH; Choi YK; Byun JK; Kim MK; Kang YN; Kim SH; Lee S; Jang BK; Park KG
    Exp Mol Med; 2016 Mar; 48(3):e213. PubMed ID: 26940882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling.
    Chen ZH; Tian Y; Zhou GL; Yue HR; Zhou XJ; Ma HY; Ge J; Wang X; Cao XC; Yu Y
    Breast Cancer Res; 2023 Feb; 25(1):22. PubMed ID: 36829181
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li D; Huang S; Luo C; Xu Y; Fu S; Liu K; Wu J
    Curr Oncol; 2023 Feb; 30(3):2653-2672. PubMed ID: 36975415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
    Wang Z; Wei W; Sun CK; Chua MS; So S
    Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.
    Delic S; Thuy A; Schulze M; Proescholdt MA; Dietrich P; Bosserhoff AK; Riemenschneider MJ
    Genes Chromosomes Cancer; 2015 Jul; 54(7):433-43. PubMed ID: 25931111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
    Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.
    Wan C; Hou S; Ni R; Lv L; Ding Z; Huang X; Hang Q; He S; Wang Y; Cheng C; Gu XX; Xu G; Shen A
    Oncogene; 2015 Jan; 34(2):237-45. PubMed ID: 24336329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
    Geng D; Zhao W; Feng Y; Liu J
    Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.